Objective: The therapeutic arsenal of hypoglycaemic drugs has been increased by the commercialization of new molecules in recent years. The main objective of this study was to know the trend of use of this group of drugs in a healthcare area.
Methods: The data was obtained through an electronic medical prescription billing computer application that contains all the information on the consumption of prescription drugs. The last seven years were analyzed in a healthcare area that covers a population of 85 thousand inhabitants and the defined daily dose (DDD) per inhabitant per day was used as a measurement variable.
Results: In our health area, an increasing and constant use of antidiabetic drugs was observed from a value of 55.62 DHD per inhabitant per day in 2014 to a value of 65.04 in 2020. Throughout the period studied, oral hypoglycemic drug combinations and sodium-glucose cotransporter-2 inhibitors were the therapeutic subgroups that experienced growth greater than 50%.
Conclusions: The consumption of hypoglycemic agents experienced a notable growth in the period analyzed, mainly at the expense of new therapeutic groups and new commercialized molecules.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Operation Polypharmacy: a pharmacist-led ambulatory care clinic design and evaluation for older patients.
Sci Rep
December 2024
Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
The unintended consequences of polypharmacy pose significant risks to older adults. The complexities of managing numerous medications from multiple prescribers demand a comprehensive approach to mitigate harms. Pharmacist-led clinics have been shown to improve outcomes in patients with diabetes and hypertension.
View Article and Find Full Text PDFHigh-risk medication errors: Insight from the UK National Reporting and learning system.
Explor Res Clin Soc Pharm
March 2025
Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia.
Background: Ensuring patient safety is of paramount importance in healthcare systems. Rising concerns about medical errors in the UK have necessitated a greater focus on studying the nature of such errors, particularly those involving high-risk medications.
Objectives: To conduct a retrospective analysis of incidents related to patient safety in the UK based on data from the National Rporting and Learning System (NRLS).
New tools to monitor infection and biofilms in .
Front Cell Infect Microbiol
December 2024
School of Biosciences, University of Kent, Canterbury, United Kingdom.
Introduction: Antimicrobial resistance is a growing health problem. Pseudomonas aeruginosa is a pathogen of major concern because of its multidrug resistance and global threat, especially in health-care settings. The pathogenesis and drug resistance of depends on its ability to form biofilms, making infections chronic and untreatable as the biofilm protects against antibiotics and host immunity.
View Article and Find Full Text PDFIntroduction: Dozens of vaccines have been approved or authorized internationally in response to the ongoing SARS-CoV-2 pandemic, covering a range of modalities and routes of delivery. For example, mucosal delivery of vaccines via the intranasal (i.n.
View Article and Find Full Text PDFCost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China.
Front Pharmacol
December 2024
Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Background: Lenalidomide is a thalidomide analog that has immunomodulatory and anti-angiogenic properties. The ECOC-ACRIN E1412 Phase II trial demonstrated that lenalidomide, when combined with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), extended survival in diffuse large B-cell lymphoma (DLBCL) patients. This study aimed to evaluate the cost-effectiveness of combining lenalidomide with R-CHOP (R2-CHOP) versus R-CHOP alone as the initial treatment for DLBCL from the perspective of the Chinese healthcare system.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!